Investigator-Institution Initiated Research - Bayer
Bayer funds investigator- or institution-led research advancing science in its key therapeutic areas, with monthly proposal reviews and a focus on innovation and unmet medical needs.
Funder: Bayer
Due Dates (Anticipated): Not specified
Funding Amounts: Amount varies by project; funding is competitive and based on proposal needs.
Summary: Supports investigator- or institution-initiated research aligned with Bayer’s therapeutic focus areas, with monthly proposal review.
Description
Bayer Healthcare invites investigator- and institution-initiated research proposals that align with its therapeutic areas of interest, including but not limited to dermatology, radiology, gynecologic therapies, hematology, multiple sclerosis, and oncology. This program is designed to foster innovative research and scientific collaboration, supporting projects that address unmet medical needs and advance clinical or non-clinical knowledge. Bayer reviews proposals on a rolling, monthly basis, with all required documentation and contracts needing completion before project initiation. Proposals may request funding, product support, or both. Approval depends on scientific merit, technical quality, alignment with Bayer’s research strategy, and available budget.
